Probiotics
Research News and Information

Sunday, November 22, 2009

Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial.

5 Oct 2009 CONTEXT: Sepsis is a common and severe complication in premature neonates, particularly those with very low birth weight (VLBW) (<1500 g). Whether lactoferrin, a mammalian milk glycoprotein involved in innate immune host defenses, can reduce the ... Read more...

Meta-analysis: Lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication.

29 Sep 2009 BACKGROUND: Recent evidence showed that Lactobacilli could exert an inhibitory effect on Helicobacter pylori both in vitro and in vivo models. To systematically evaluate whether adding Lactobacilli to H. pylori eradication regimens could improve ... Read more...

New insights into the pathogenesis of Crohn's disease: are they relevant for therapeutic options?

17 Sep 2009 During the last few years significant advances have been achieved in the understanding of the pathogenesis of inflammatory bowel disease (IBD). A genetic susceptibility to Crohn's disease has been proven by identification of variations as risk ... Read more...

Latest indexed articles for 'Probiotics'

These are the very latest articles for this heading:

• Lactoferrin supplementation to prevent nosocomial infections in preterm infants. 5 Oct 2009
• Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. 5 Oct 2009
• Meta-analysis: Lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication. 29 Sep 2009
• New insights into the pathogenesis of Crohn's disease: are they relevant for therapeutic options? 17 Sep 2009
• Rational design of improved pharmabiotics. 8 Sep 2009
• Emerging drugs for the treatment of ulcerative colitis. 30 Aug 2009
• Evaluation of PCR and DNA sequencing for direct detection of Clostridium perfringens in the intestinal tract of broilers. 30 Aug 2009
• Probiotic lactobacilli in breast milk and infant stool in relation to oral intake during the first year of life. 30 Aug 2009
• Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics. 30 Aug 2009
• Assessment of antibiotic resistance in probiotic strain Lactobacillus brevis KB290. 30 Aug 2009
• Drugs for inflammatory bowel disease. 30 Aug 2009
• Probiotic microbes: do they need to be alive to be beneficial? 30 Aug 2009
• Diet, fecal water, and colon cancer--development of a biomarker. 30 Aug 2009
• Gastrointestinal microflora, food components and colon cancer prevention. 25 Aug 2009
• Genome of a virulent bacteriophage Lb338-1 that lyses the probiotic Lactobacillus paracasei cheese strain. 23 Aug 2009
• Oral administration of live Bifidobacterium substrains isolated from centenarians enhances intestinal function in mice. 20 Aug 2009
• Probiotics and prebiotics: immunological and clinical effects in allergic disease. 17 Aug 2009
• Microbial-host interactions: selecting the right probiotics and prebiotics for infants. 17 Aug 2009
• Obesity - extending the hygiene hypothesis. 17 Aug 2009
• Browning of freeze-dried probiotic bacteria cultures in relation to loss of viability during storage. 10 Aug 2009

See a longer list of these articles.

Technical information about 'Probiotics'

Definition: Live microbial DIETARY SUPPLEMENTS which beneficially affect the host animal by improving its intestinal microbial balance. Antibiotics and other related compounds are not included in this definition. In humans, lactobacilli are commonly used as probiotics, either as single species or in mixed culture with other bacteria. Other genera that have been used are bifidobacteria and streptococci. (J. Nutr. 1995;125:1401-12)

Descriptor UI: D019936

Alternative terms: Probiotics; Probiotic;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; chemical synthesis; classification; diagnostic use; economics; history; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; chemistry; contraindications;

Tree Number: J02.500.456.500;

History Note: 98

Technical Notes: coordinate with specific microorganism